<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02773173</url>
  </required_header>
  <id_info>
    <org_study_id>IPPCollapse-II</org_study_id>
    <nct_id>NCT02773173</nct_id>
  </id_info>
  <brief_title>Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery Versus Standard Therapy (IPPCollapse-II)</brief_title>
  <official_title>Individualized Pneumoperitoneum Pressure in Colorectal Laparoscopic Surgery Versus Standard Therapy (IPPCollapse II)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigacion Sanitaria La Fe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigacion Sanitaria La Fe</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the post-operative recovery quality of the
      Individualized Pneumoperitoneum Pressure Therapy in Colorectal laparoscopic surgery versus
      standard therapy using a quality validated scale of postoperative recovery of their stay in
      the Post-Anaesthesia Recovery Unit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the last two decades laparoscopic surgery has settled as a less invasive surgical approach
      compared to open surgery. It is associated with lower perioperative morbidity and hospital
      stay. There is growing evidence that increased intra-abdominal pressure (IAP), even for short
      periods of time, is associated with increased perioperative morbidity (pain, increased
      inflammatory markers peritoneal injury worse splanchnic perfusion abnormalities hemodynamic
      and ventilatory ...).

      The study is a prospective multicenter randomized clinical intervention trial to assess the
      impact of IAP individualization strategy (IPP-Individualized pneumoperitoneum Pressure)
      relative to a IAP standard strategy (SPP-Standard pneumoperitoneum Pressure) using a
      validated scale (VAS) (PQRS- Postoperative Quality of Recovery Scale). Postoperative pain in
      the first 24 hours (area under VAS curve , opioid rescue, referred pain to the shoulder) and
      surgical stress and inflammatory markers (neutrophil/lymphocyte, ratio,C-reactive protein,
      interleukin-6, procalcitonin) are also measured. Postoperative complications are evaluated by
      Clavier-Dindo classification.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 25, 2017</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Quality of Recovery Scale (PQRS)</measure>
    <time_frame>Baseline and after admission to PACU (postanesthesia care unit) at 15 minutes (T15)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Quality of Recovery Scale (PQRS)</measure>
    <time_frame>Baseline and after admission to PACU (postanesthesia care unit) at 40 minutes (T40) .</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Quality of Recovery Scale (PQRS)</measure>
    <time_frame>Postoperatively on day 1 (POD1).</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Quality of Recovery Scale (PQRS)</measure>
    <time_frame>Postoperatively on day 3 (POD3).</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients characteristics (demographic data)</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Previous experience with low IAP</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of laparoscopic surgery</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>laparoscopic surgery-cases annually</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Basic features of airway pressures (plateauP, peakP, pulmonary Compliance)</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spontaneous / coughing movements.</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain (area under VAS,opioid rescue,referred pain to the shoulder)</measure>
    <time_frame>In the first 24 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical stress and inflammatory markers (neutrophil/lymphocyte ratio, C-reactive protein,interleukin-6 and procalcitonin).</measure>
    <time_frame>In the first 24 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selected complications (scale of Clavier-Dindo).</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inpatient days.</measure>
    <time_frame>Day 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure (IAP)</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure (IAP)</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure (IAP)</measure>
    <time_frame>Day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure with volume 0 (PV0)</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure with volume 0 (PV0)</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure with volume 0 (PV0)</measure>
    <time_frame>Day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure (IAP) max</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure (IAP) max</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-abdominal pressure (IAP) max</measure>
    <time_frame>Day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Years of Surgeon experience in laparoscopic surgery</measure>
    <time_frame>Day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dynamic compliance (Vt / Peak Pressure (P1))</measure>
    <time_frame>During surgery</time_frame>
    <description>Dynamic compliance is determinated using the airway pressure peak. Dynamic Compliance = Vt / Peak Pressure (P1)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">190</enrollment>
  <condition>Colorectal Surgery</condition>
  <condition>Laparoscopy</condition>
  <arm_group>
    <arm_group_label>Individualized Pneumoperitoneum Pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Individualized Pneumoperitoneum Pressure (IPP) group, measures to optimize and individualize intra-abdominal pressure (PIA) will be apply.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Pneumoperitoneum Pressure</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In Standard Pneumoperitoneum Pressure (SPP) group, a conventional operation without optimization measures and PIA preset to 12 mmHg will be conducted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IPP in colorectal laparoscopic surgery</intervention_name>
    <description>Deep neuromuscular blockade can only be reversed with sugammadex, so in the IPP group, it will be used as neuromuscular blocking agent and its effect will be reversed with sugammadex (4mg / kg) at the end of the surgery. During surgery: deep neuromuscular blockade (PTC 1-5), Protective ventilation strategy, Optimal position and Pre stretching as a tool to decrease intraabdominal pressure maintaining optimal workspace.</description>
    <arm_group_label>Individualized Pneumoperitoneum Pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SPP in colorectal laparoscopic surgery</intervention_name>
    <description>A depolarizing neuromuscular blocking will be used (as routine clinical practice at each center) to maintain moderate neuromuscular blockade and its effect will be reversed with anticholinesterase at the end of the surgery. During surgery: Moderate neuromuscular blockade ( TOF 2-4) , position to surgeon criteria, no prestretching and Protective ventilation. Fixed IAP (12mmHg).</description>
    <arm_group_label>Standard Pneumoperitoneum Pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years

          -  Classification of the American Society of Anesthesiologists (ASA I-III)

          -  No cognitive deficits

          -  Signed informed consent prior to surgery

        Exclusion Criteria:

          -  Emergency surgery

          -  Pregnancy or lactation

          -  Immune disorders

          -  Kidney or liver disease or advanced-stage cardiopulmonary

          -  Patient refusal to participate in the study

          -  Patients under 18 years or inability to consent

          -  Associated neuromuscular disorders, contraindication for the use of rocuronium/
             sugammadex, allergy or hypersensitivity to rocuronium / sugammadex
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Óscar Díaz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Investigación Sanitaria La Fe</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Cortell</last_name>
    <phone>0034961246611</phone>
    <email>investigacion_clinica@iislafe.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital universitario y Politécnico La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Cortell</last_name>
      <phone>0034961246611</phone>
      <email>investigacion_clinica@iislafe.es</email>
    </contact>
    <contact_backup>
      <last_name>Laura Segura</last_name>
      <phone>0034961246611</phone>
      <email>monitor1@iislafe.es</email>
    </contact_backup>
    <investigator>
      <last_name>Óscar Díaz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2016</study_first_submitted>
  <study_first_submitted_qc>May 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2016</study_first_posted>
  <last_update_submitted>April 20, 2017</last_update_submitted>
  <last_update_submitted_qc>April 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal Laparoscopic Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumoperitoneum</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

